|
ZNF708 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.150400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.774800E-01 |
| Normal-vs-Stage2 |
3.900000E-01 |
| Normal-vs-Stage3 |
3.126200E-01 |
| Normal-vs-Stage4 |
3.541800E-02 |
| Stage1-vs-Stage2 |
4.662800E-01 |
| Stage1-vs-Stage3 |
2.687400E-01 |
| Stage1-vs-Stage4 |
1.558080E-02 |
| Stage2-vs-Stage3 |
2.146800E-01 |
| Stage2-vs-Stage4 |
7.906200E-02 |
| Stage3-vs-Stage4 |
3.584400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.577200E-01 |
| Normal-vs-AfricanAmerican |
2.185800E-01 |
| Normal-vs-Asian |
4.306800E-01 |
| Caucasian-vs-AfricanAmerican |
2.064400E-01 |
| Caucasian-vs-Asian |
6.397000E-01 |
| AfricanAmerican-vs-Asian |
1.316240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.743600E-01 |
| Normal-vs-Female |
1.003440E-01 |
| Male-vs-Female |
7.319800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.788400E-01 |
| Normal-vs-Extreme_Weight |
6.400400E-01 |
| Normal-vs-Obese |
2.462000E-01 |
| Normal-vs-Extreme_Obese |
8.325200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.006600E-01 |
| Normal_Weight-vs-Obese |
2.113600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.245000E-01 |
| Extreme_Weight-vs-Obese |
1.367180E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.944800E-01 |
| Obese-vs-Extreme_Obese |
7.047400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.390200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.283600E-02 |
| Normal-vs-Age(61-80Yrs) |
6.968400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.482000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.176200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.565000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.588400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.119800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.707630E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.826420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.361600E-01 |
| Normal-VS-Type2 PRCC |
5.963400E-03 |
| Normal-VS-KIRP CIMP |
2.611600E-01 |
| Normal-VS-Unclassified PRCC |
2.894200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.03340000001673E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.182600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.535600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.159600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.016200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.218200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.613390E-01 |
| Normal-vs-N1 |
9.780800E-01 |
| Normal-vs-N2 |
6.419200E-03 |
| N0-vs-N1 |
2.439000E-01 |
| N0-vs-N2 |
1.195040E-01 |
| N1-vs-N2 |
5.100000E-02 |
|
|
